Gahyun Gim, MD
Clinical Assistant Professor
On This Page
About Gahyun Gim
I work as a hematology and oncology specialist here at UF Health and am board certified in internal medicine by the American Board of Internal Medicine. My position at UF Health was preceded by an educational journey that started in Busan, South Korea, where I received my medical degree in 2015 from the Kosin University College of Medicine . I continued my medical education in 2018 with a residency in internal medicine at St. Elizabeth’s Medical Center in Boston , then affiliated with Tufts University School of Medicine. After this residency, I completed a fellowship in hematology and medical oncology at the Wilmot Cancer Center at the University of Rochester Medical Center in New York .
Board Certifications
-
Internal MedicineAmerican Board of Internal Medicine
Clinical Profile
Specialties
- Hematology and Oncology
Publications
Academic Articles
-
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.
- Journal
- The oncologist.
- Volume/Issue
- 27(7):525-531
- [DOI]
- 10.1093/oncolo/oyac095.
- [PMID]
- 35640145.
-
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.
- Journal
- The oncologist.
- Volume/Issue
- 27(6):e471-e483
- [DOI]
- 10.1093/oncolo/oyac036.
- [PMID]
- 35348765.
-
Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherapy as first-line therapy.
- Journal
- Heliyon.
- Volume/Issue
- 7(9)
- [DOI]
- 10.1016/j.heliyon.2021.e07916.
- [PMID]
- 34568594.
-
Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis.
- Journal
- Translational lung cancer research.
- Volume/Issue
- 10(4):1700-1710
- [DOI]
- 10.21037/tlcr-20-933.
- [PMID]
- 34012786.
-
Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).
- Journal
- Cancer immunology, immunotherapy : CII.
- Volume/Issue
- 70(4):961-965
- [DOI]
- 10.1007/s00262-020-02703-8.
- [PMID]
- 33084943.
Grants
-
BillionToOne<>University of Florida GI Oncology Group Study Collaboration Proposal
Active
- Role:
- Co-Project Director/Principal Investigator
- Funding:
- BILLIONTOONE
Education
-
Fellowship, Hematology and Medical Oncology
Wilmot Cancer Center, University of Rochester Medical Center
-
Residency, Internal Medicine
Tufts University School of Medicine/St. Elizabeth’s Medical Center
-
Medical Degree
Kosin University College of Medicine
Contact Details
- Business:
- (352) 273-7832
- Business:
- ggim@ufl.edu
- Business Street:
-
PO Box 100278
GAINESVILLE FL 32611